Remote Patient Monitoring Market 2026 | Size, Share, Growth, Trends and Forecast
Remote
Patient Monitoring Market Overview:
The United States accounts for a significant share of
the global remote patient
monitoring (RPM) market. The U.S. RPM market alone is
projected to represent an opportunity exceeding $18 billion by 2026, growing at
a robust CAGR of approximately 25% between 2021 and 2026. This growth is being
fueled by the rising prevalence of chronic diseases, the introduction of new
CMS reimbursement and CPT codes, the pandemic-driven shift of care delivery
from hospitals to home settings, and rapid advancements in RPM hardware,
software, and clinical care capabilities.
Year-End
Mega Sale: Get Up to 10% Off on All Market Research Reports!
According to Medi-Tech Insight’s latest analysis, the
global remote patient monitoring market presents substantial, largely untapped
growth potential. The report provides an in-depth examination of key growth
drivers, pricing dynamics, the competitive landscape, segment-level analysis,
product and offering mapping, and emerging white-space opportunities.
Healthcare is evolving rapidly, driven by continuous
technological innovation and expanding service models. One of the most
impactful developments is remote patient monitoring, which offers meaningful
advantages in a world facing an aging population and a growing burden of
chronic illnesses. Advances in communication and sensor technologies now enable
patient monitoring not only within hospital environments but also in home
settings. Modern RPM solutions can track multiple vital parameters, including
blood pressure, heart rate, respiratory rate, ECG readings, temperature, and
blood glucose levels. These technologies are increasingly used to monitor
diverse patient groups, such as individuals with chronic conditions, accident
victims, elderly patients, and premature infants.
Key Influencing Factors in the Global
Remote Patient Monitoring Market
Growth Drivers
- Introduction of CMS-approved expanded CPT codes for Remote
Therapeutic Monitoring (RTM) in 2022 (98975, 98976, 98977, 98980, and
+98981), enabling reimbursement for monitoring and interpretation of
non-physiological data related to respiratory and musculoskeletal systems,
therapy adherence, and treatment response.
- Earlier rollout of RPM CPT reimbursement codes in 2019 (99453,
99454, 99457) and 2020 (99458), which significantly accelerated adoption
of RPM services.
- Increasing prevalence of chronic diseases and mounting pressure to
reduce overall healthcare costs.
- Growing recognition of RPM as a proactive care tool that improves
patient engagement while reducing emergency department visits, hospital
readmissions, and lengths of stay.
- Presence of more than 200 small and mid-sized companies, fostering
competition, innovation, and market expansion.
- A favorable investment climate supporting RPM and telehealth
solutions.
Market Barriers and Challenges
- Continuous data monitoring poses challenges for clinicians,
including alert fatigue and the burden of 24/7 data review.
- Patient readiness and data privacy concerns, particularly among
older and less tech-savvy populations.
- Difficulties integrating third-party RPM data seamlessly into
existing electronic health record (EHR) systems.
Download Sample: https://meditechinsights.com/remote-patient-monitoring-market/request-sample/
Impact of COVID-19 on the RPM Market
The COVID-19 pandemic significantly accelerated
adoption of remote patient monitoring, highlighting its value in maintaining
continuity of care while minimizing exposure risks. The next phase of market
growth is expected to be driven by sustained adoption during and beyond the
pandemic, increased demand for cost-effective care models, and improved
outcomes for patients with chronic conditions. Financial incentives and patient
demand are also boosting post-acute care adoption, particularly in specialties
such as cardiology and orthopedics.
User Segments and Market Structure
While healthcare providers remain the largest users of
RPM solutions, other high-growth segments—including health plans and payors,
employers, home health agencies, and clinical trial organizations—are expected
to expand rapidly over the next five years.
The global RPM market is highly fragmented, with over
200 companies competing in this emerging space. This fragmentation underscores
the importance of well-defined pricing strategies and effective go-to-market
approaches. Companies from adjacent sectors, such as telehealth and personal
emergency response systems (PERS), are also entering the RPM market, as
evidenced by major acquisitions like Teladoc’s acquisition of Livongo.
Key Growth Strategies for RPM
Companies
- Developing comprehensive, integrated solutions tailored to specific
chronic conditions such as diabetes, COPD, and hypertension.
- Leveraging AI and machine learning to enhance patient engagement,
adherence, and outcomes.
- Moving beyond data collection to enable population health management
for providers.
- Forming partnerships with technology vendors, device manufacturers,
and care delivery organizations to create end-to-end care pathways.
- Pursuing strategic mergers and acquisitions to expand geographic
reach, disease coverage, and operational scale.
Business Models and Competitive
Landscape
The subscription-based model remains the most prevalent
business model in the RPM market. Under this approach, RPM vendors provide
devices and software platforms to healthcare providers, who then deploy these
solutions to patients for ongoing remote monitoring.
The competitive landscape includes both established
players and emerging companies. Key participants in the global RPM market
include Vivify Health, Health Recovery Solutions, Teladoc–Livongo, Amwell, AMC
Health, Careclix, Ontrak, Accuhealth, iHealth Labs, and others. Many innovative
companies are differentiating themselves by refining business models, enhancing
product and service offerings, and tailoring pricing strategies based on
customer segment, geographic reach, population health metrics, and the
continuum of care addressed.
Browse Report: https://meditechinsights.com/remote-patient-monitoring-market/
Future Outlook
The outlook for the global remote patient monitoring
market remains highly promising. Continued investments in RPM and telehealth,
increased emphasis on post-acute and home-based care, advancements in
technology and artificial intelligence, a growing elderly population, and the
entry of new market players are expected to drive sustained growth. Key
benefits of RPM—including reduced infection risk, faster access to patient
data, improved outcomes, optimized use of healthcare resources, and cost
savings—will further support market expansion.
Today represents a unique window of opportunity for
stakeholders to capitalize on this high-growth market by adopting the right
strategies and leveraging deep industry expertise.
Related Report:
· HPV
Testing and PAP Test Market https://www.pharmiweb.com/press-release/2025-12-18/hpv-testing-and-pap-test-market-share-size-growth-forecast-till-2030
· Cellular
Health Screening Market https://www.pharmiweb.com/press-release/2025-12-18/cellular-health-screening-market-2030-analysis-size-share-growth-trends-and-forecast
· Hematology
Market https://www.pharmiweb.com/press-release/2025-12-18/hematology-market-outlook-2030-industry-trends-and-competitive-analysis
· Long-Term
Care Software Market https://www.pharmiweb.com/press-release/2025-12-18/long-term-care-software-market-demand-for-evidence-based-medicine-and-research-updates
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research &
insights firm. Our clients include Fortune 500 companies, blue-chip investors
& hyper-growth start-ups. We have completed 100+ projects in Digital
Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services
in the areas of market assessments, due diligence, competitive intelligence,
market sizing and forecasting, pricing analysis & go-to-market strategy.
Our methodology includes rigorous secondary research combined with deep-dive
interviews with industry-leading CXO, VPs, and key demand/supply side
decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
Comments
Post a Comment